TY - JOUR
T1 - A multi-level intervention to eliminate hepatitis C from the Region of Southern Denmark
T2 - the C-Free-South project
AU - Dröse, Sandra
AU - Øvrehus, Anne Lindebo Holm
AU - Holm, Dorte Kinggaard
AU - Madsen, Lone Wulff
AU - Mössner, Belinda Klemmensen
AU - Søholm, Jacob
AU - Hansen, Janne Fuglsang
AU - Røge, Birgit Thorup
AU - Christensen, Peer Brehm
N1 - © 2022. The Author(s).
PY - 2022/3/1
Y1 - 2022/3/1
N2 - Denmark has signed the WHO strategy to eliminate hepatitis C virus (HCV). In the absence of a national strategy for elimination, a local action plan was developed in the Region of Southern Denmark (RSD). The aim of the strategy is to diagnose 90% of HCV-infected persons and treat 80% of those diagnosed by 2025. The strategy was developed by reviewing Danish data on HCV epidemiology and drug use to identify key populations for screening, linkage to care, and treatment. Based on available published data from 2016, an estimated 3028 persons in the RSD were HCV-RNA positive (population prevalence 0.21%). Of these, 1002 were attending clinical care, 1299 were diagnosed but not in clinical care, and 727 were undiagnosed. Three different interventions targeting the HCV-infected population and two interventions for HCV surveillance are planned to achieve elimination. The "C-Free-South" strategy aims to eliminate HCV in our region by identifying (90%) and treating (80%) of infected persons by the end of 2025, 5 years earlier than the WHO elimination target date.
AB - Denmark has signed the WHO strategy to eliminate hepatitis C virus (HCV). In the absence of a national strategy for elimination, a local action plan was developed in the Region of Southern Denmark (RSD). The aim of the strategy is to diagnose 90% of HCV-infected persons and treat 80% of those diagnosed by 2025. The strategy was developed by reviewing Danish data on HCV epidemiology and drug use to identify key populations for screening, linkage to care, and treatment. Based on available published data from 2016, an estimated 3028 persons in the RSD were HCV-RNA positive (population prevalence 0.21%). Of these, 1002 were attending clinical care, 1299 were diagnosed but not in clinical care, and 727 were undiagnosed. Three different interventions targeting the HCV-infected population and two interventions for HCV surveillance are planned to achieve elimination. The "C-Free-South" strategy aims to eliminate HCV in our region by identifying (90%) and treating (80%) of infected persons by the end of 2025, 5 years earlier than the WHO elimination target date.
KW - Elimination
KW - Epidemiology
KW - Hepatitis C virus
KW - Interventions
KW - Testing
KW - Treatment
U2 - 10.1186/s12879-022-07196-7
DO - 10.1186/s12879-022-07196-7
M3 - Journal article
C2 - 35232372
SN - 1471-2334
VL - 22
JO - B M C Infectious Diseases
JF - B M C Infectious Diseases
M1 - 202
ER -